COMP <GO>
AMLX vs ACAD // EV/EBITDA & P/E VALUATION
Amylyx Pharmaceuticals Inc. (NASDAQ) VS. ACADIA Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: AMLX 2
— ACAD 3
■ METRIC PARITY
LAST: $28.68 (+2.17%) • MKT CAP: $3.60B
valuation
—
LAST: $20.76 (+2.17%) • MKT CAP: $3.58B
valuation
31.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMLX VS. ACAD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMLX | ACAD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 91.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 7.90% | -42.90 | ACAD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 31.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.43% | 2.94% | -6.37 | ACAD | /fcf-yield <GO> |
| Operating Margin | — | 9.80% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 36.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 11.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 6.26 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | ACAD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 45.5 | +6.37 | AMLX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 8.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.60B | $3.58B | $21.1M | AMLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMLX REV | ACAD REV | AMLX GROSS % | ACAD GROSS % | AMLX FCF | ACAD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.07B | — | 91.7% | -$123.5M | $105.1M |
| FY 2024 | $87.4M | $957.8M | 93.2% | 91.5% | -$167.8M | $157.2M |
| FY 2023 | $380.8M | $726.4M | — | — | $11.9M | $16.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMLX // BETA —
ACAD // BETA —